Introduction {#S0001}
============

As a well-known dangerous disease, acute myocardial infarction (AMI) is associated with a high incidence of mortality and morbidity.[@CIT0001] Compared with patients with other sites of AMI, patients with anterior wall infarctions suffer from a greater risk of death and cardiovascular events. From previous reports, the 1-year mortality rate after anterior AMI ranges from 6--10%.[@CIT0002] A formal risk assessment for identifying high-risk patients is essential in clinical practice and promoted in guidelines for the management of AMI. Traditionally, the most commonly used risk assessment tools are derived from the Thrombolysis in Myocardial Infarction (TIMI)[@CIT0003] and Global Registry of Acute Coronary Events (GRACE).[@CIT0004] These risk scores were developed from conventional statistical methods and are accompanied by some inherent limitations from missing value imputation, feature selection, model development and validation.

Machine learning is a method that combines data science and statistical techniques to give computers the ability to learn from training set and solve the task without being explicitly programmed. The path of machine learning avoids priori assumptions of the model, which may offer additional knowledge and information. This method has been gradually applied in clinical practice and in the field of cardiology. Each algorithm has its own strength in different fields. In this study, we sought to evaluate the performance of different machine learning models (including naïve Bayes (NB), logistic regression, k nearest neighbours (KNN), decision tree, random forest and XGBoost) in predicting the 1-year mortality rate of anterior ST-segment elevation myocardial infarction (STEMI) patients and to compare the utility of these models to the conventional GRACE risk score risk scores.

Method {#S0002}
======

This study was conducted with a hospital-based dataset. We consecutively enrolled aged \>18 years patients with discharge diagnoses of acute anterior wall myocardial infarctions in the Western China Hospital, Sichuan University, from January 2011 to January 2017. The patients with anterior STEMI were eligible for inclusion if they were restricted to participants with 1) ischemic chest discomfort that increased or occurred at rest; 2) ST segment elevation ≥ 0.1 mV in ≥2 contiguous anterior leads; 3) elevated cardiac troponin I levels (≥0.03 μg/L) or elevated cardiac troponin T levels (≥42 ng/L).[@CIT0005] The collection of patient data included the demographic information, baseline characteristics at admission, diagnosis and treatment during hospitalization, discharge diagnoses and medication, and approximately 59 features. The follow-up period ended in January 2018. The follow-up information was collected through contact with the patients' physicians and patients or their families. These inclusion and exclusion criteria were met by 1305 anterior STEMI patients enrolled from the database. After excluding patients who were lost to follow-up (n = 61), 1244 patients were included in the data analysis. The baseline demographics and clinical characteristics were compared between the non-surviving patients and survivors after a 1-year follow-up. Continuous variables are expressed as the mean ± standard deviation (SD), and categorical variables are reported as counts and percentages. *T*-tests and chi-squared tests were used to evaluate the differences in continuous and categorical variables between groups, respectively. The GRACE risk score used to analyse mortality has been described previously, and the calculation was performed following the published formula.

Six machine learning classifiers (GaussianNB, logistic regression, KNN, decision tree, random forest and XGBoost) were both supervised methods and applied to predict the survival status after a 1-year follow-up. The supervised learning aims to build the concise models of the distribution of class outcomes (in machine learning, called labels) in terms of predictor parameters.[@CIT0006] All models were validated with 10-fold cross-validation. In feature engineering, all the categorical features were transformed by one-hot encoding, and the missing value was imputed by the missForest method,[@CIT0007] which had a noticeable improvement in performance compared to traditional methods such as multiple imputation with chained equations. For feature importance ranking, we use two tree-based methods, random forest and XGBoost. The performance of the model was defined by the following metrics: area under the curve (AUC) of the receiver operating characteristic curve (ROC), sensitivity, specificity and f1 score.

Data analyses were performed using Python (version 3.7) with the scientific libraries "scikit-learn", "XGBoost" and Stata (Release 15. College Station, TX: StataCorp LLC).

Results {#S0003}
=======

From January 2011 to January 2017, a total of 1244 patients were included in this study. The mean patient age was 63.8±12.9 years, and the proportion of males was 78.4%. The majority (985, 75.18%) received reperfusion therapy. The average follow-up period was 36.7 months. There were 185 patients who died within 1 year after admission (mortality rate was 14.87%). The baseline characteristics of this study population were stratified according to patients who survived until the 1-year period and those who died. The differences in demographic information, baseline characteristics of admission, and treatment during hospitalization between the two groups are summarized in [Table 1](#T0001){ref-type="table"}. The details of all 59 features are listed in are list in [[supplement 1](https://www.dovepress.com/get_supplementary_file.php?f=236498.docx)]{.ul}.Table 1Clinical Characteristics of the Study PopulationCharacteristicsTotalPatients SurvivedPatients DiedP-valueNo. of patients12441059185Age63.76±12.9262.16 ± 12.6372.91±10.51\<0.001Male975 (78.38%)855 (80.74%)120 (64.80%)\<0.001smoke780 (62.70%)680 (64.21%)100 (54.05%)0.008**Medical history** Pre-hypertension, n (%)580 (46.62%)480 (45.89%)94 (50.81%)0.216 Pre-diabetes mellitus, n (%)260 (20.90%)211 (19.92%)49 (26.49%)0.043 Pre-COPD, n (%)131 (10.53%)92 (8.69%)39 (21.08)\<0.001 History of chest pain, n (%)257 (20.66%)219 (20.68%)38 (20.54%)0.002**At admission** HR, beats/min83.83 ± 16.8581.56 ± 15.5995.15 ± 19.18\<0.001 SBP, mm Hg125.29 ± 22.06125.93 ± 22.21121.57 ± 20.800.013 DBP, mm Hg77.21 ± 22.8577.59 ± 24.0775.59 ± 13.900.296 LVEF, %49.36 ± 10.5950.69 ± 10.1641.75 ± 9.78\<0.001 Cardiac arrest, %18 (1.45%)16 (1.51%)2 (1.09%)0.652**Risk assessment** GRACE risk score176.47 ± 38.60169.99 ± 34.11213.61 ± 40.80\<0.001 Killip classification ≥2348 (27.97%)213 (20.11%)135 (72.97%)\<0.001**Laboratory values** Serum creatinine, μmol/L94.70 ± 63.1687.65 ± 52.52135.10 ± 95.73\<0.001 Blood glucose, mmol/L9.03 ± 4.148.68 ± 3.7511.04 ± 5.51\<0.001 Cystatin C, mg/L1.12 ± 0.591.04 ± 0.441.60 ± 0.99\<0.001 BNP, pg/mL3999.61 ± 7180.382780.16 ± 5243.1110,980.16 ± 11,518.47\<0.001 BUN, mg/dL7.07 ± 4.236.48 ± 3.3210.43 ± 6.65\<0.001 T-Bil, umol/L13.84 ± 7.6413.54 ± 7.3015.56 ± 7.20\<0.001 Fibrinogen, g/L3.35 ± 1.283.28 ± 1.213.78 ± 1.54\<0.001**Revascularization type**\<0.001 Non224 (18.01%)131 (12.37%)93 (50.27%) Primary PCI582 (46.78%)521 (49.20%)61 (32.97%) Selective PCI377 (30.31%)255 (33.52%)22 (11.89%) Thrombolysis18 (1.45%)17(1.61%)1 (0.54%) Rescue PCI5 (0.40%)4 (0.37%)1 (0.54%) Selective CABG3 (0.24%)3 (0.28%)0 (0%) CAG only35 (2.81%)28 (2.64%)7 (3.78%)**At discharge** NYHA classification ≥2124 (9.97%)73 (6.89%)51 (27.57%)\<0.001[^2]

Six machine learning algorithms (GaussianNB, logistic regression, KNN, decision tree, random forest and XGBoost) were developed to predict the overall 1-year mortality rate post STEMI with all available features. All the hyperparameters of the models were set carefully following the tutorials or preliminary experiment. The XGBoost classifier (AUC=0.942) outperformed the other models in terms of the ROC cross validation results (logistic regression (AUC=0.931), Gaussian naïve Bayes (AUC=0.924), KNN (AUC=0.709), decision tree (AUC=0.772), random forest (AUC=0.932)) ([Figure 1](#F0001){ref-type="fig"}). The other metrics of each model are summarized in [Table 2](#T0002){ref-type="table"}. XGBoost also achieved the highest accuracy (92%), specificity (99%) and F1 score (0.74). Regarding sensitivity, the Gaussian naïve Bayes (77%) and random forest (75%) algorithms performed better than the other models. The AUC of the GRACE risk score was 0.794, and the metrics are summarized in [Table 2](#T0002){ref-type="table"}.Table 2Comparison of Validation Results of Six Machine Learning ModelsModels with All FeaturesModelsAccuracy (%)Sensitivity (%)Specificity (%)F1 Score\*Logistic regression8749950.57GaussianNB8877900.68KNN8219950.27Decision tree8664900.61Random forest8875910.69XGBoost9260990.74Models after feature selectionLogistic regression8840980.53GaussianNB8760920.61KNN8317970.26Decision tree9051980.63Random forest8975920.71XGBoost9260990.73Traditional risk scoreGRACE risk score8616980.26[^3][^4] Figure 1ROC analysis result of six classifiers for the prediction of 1-year mortality with all available features.**Abbreviation:** ROC, receiver operating characteristic curve.

Moreover, we selected the repeat features with top-20 feature-ranking with the random forest and XGBoost methods, including the following 15 variables: New York Heart Association (NYHA) Classification at discharge, heart failure at admission, heart rate, age, left ventricular ejection fraction, serum cystatin, initial BNP, Platelet, Fibrinogen, Blood creatinine, blood glucose, systolic blood pressure, diastolic blood pressure, total bilirubin, blood urea nitrogen, and revascularization type. The ROC analysis results of each model are presented in [Figure 2](#F0002){ref-type="fig"}, in which the random forest method showed the highest AUC (0.943). However, the XGBoost still showed the highest accuracy (92%), specificity (99%) and f1 score (0.73) ([Table 2](#T0002){ref-type="table"}).Figure 2ROC analysis result of six classifiers for the prediction of 1-year mortality with 20 top features.**Abbreviation:** ROC, receiver operating characteristic curve.

Discussion {#S0004}
==========

Although STEMI is associated with a poor prognosis and a high incidence of death and cardiovascular events, especially those located in the anterior wall, it is still difficult to predict the long-term outcomes of these patients. Usually, the GRACE risk score is used to estimate the follow-up outcomes after acute coronary syndrome, and the 2.0 version expanded upon the original version for long-term prediction. However, these traditional assessment tools were derived from statistical methods. In these Cox proportional hazards regression models, the researcher carried pre-assumptions and performed subjective feature selection before model fitting, which thus may lead to a loss of potential knowledge.

The idea of machine learning has been gradually applied for medical data analysis or image recognition. In the current study, we compared six popular supervised algorithms and investigated the utility of machine learning for predicting the 1-year mortality rate of a Chinese myocardial infarction population. In two previous articles, the random forest method demonstrated better prediction ability for short-term mortality after STEMI than the other machine learning classifiers (without XGBoost).[@CIT0008],[@CIT0009] However, we found a noticeable improvement in the prediction ability of the XGBoost algorithm in both the full variable model and after feature ranking selection compared with other machine classifiers and conventional risk scores. Although both algorithms are based on decision trees as random forests, XGBoost is derived from boosting rather than bagging. This method powerfully reduces variance and reduces bias.[@CIT0010] As a novel algorithm published in 2016, XGBoost has gained wide popularity in the data science community. Recently, numerous reports have demonstrated that this method can be generalized and has robustness in clinical practice.[@CIT0011],[@CIT0012] Moreover, the high accuracy of this model from our work also confirmed this opinion.

Our work has several limitations due to the retrospective design of the study. The patient enrolment and data collection processes may be accompanied by selection or measurement bias, and we could not evaluate the effect of the model on direct interventions. Furthermore, this is a single-centre study that included only Chinese patients. Nonetheless, the results of the cross-validation analysis of the machine learning model still provides an effective and robust method for predicting the 1-year mortality rate of patients after anterior STEMI.
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